Ledger.Open graph →

SEC Form D · filed August 15, 2022

Enalare Therapeutics Inc

Offering

$55.0M

Sold

$12.5M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

PRINCETON, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Joseph Pergolizzi · Naples, FLExec · Director Khalid Naeem · Vancouver, British Columbia, CanadaDirector Scott Cohen · Brooklyn, NYExec Herman Cukier · Princeton, NJExec · Director Mark Coleman · Princeton, NJDirector Joseph Petko · Princeton, NJDirector Haitham Al-Beik · MARLBOROUGH, MAExec · Director Robert Yedid · Princeton, NJDirector Hari Rao · MARLBOROUGH, MADirector Daniel Motto · Princeton, NJExec Patrick Duncan · Charleston, SCDirector Enoch Kong · Vancouver, British Columbia, CanadaDirector David B. Rendina · Jupiter, FLExec · Director Alana Palmedo · San Francisco, CADirector Anthony Morena · NY, NYDirector Anthony Burns · Miami, FLDirector Brenden M. Smith · Mill Valley, CAExec · Director Greg Litvak · Denver, COExec Gino Santini · Princeton, NJDirector Daniel Zinn · Santa Monica, CADirector Reena Jashnani-Slusarz · San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗